Aptus Pharma Limited - trading in Daskroi, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2010PLC061957 Incorporated 12 August 2010 ROC Ahmedabad HQ Daskroi, Gujarat, India
Active Public Limited Company trading
Data last updated
Revenue · FY 2025
₹24.64 Cr
▲ 38% YoY
Net profit · FY 2025
₹2.96 Cr
Net margin 12%
EBITDA · FY 2025
₹4.83 Cr
EBITDA margin 19.6%
Authorised capital
₹7.15 Cr
Registered with MCA
Paid-up capital
₹6.86 Cr
Issued & subscribed
Open charges
₹5 Cr
Satisfied ₹3 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
28
Provident fund records

About Aptus Pharma Limited

Data last updated:

Aptus Pharma Limited is a public limited company based in Daskroi, Gujarat, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 12 August 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PLC061957. Its GSTIN is 24AAICA7890D1ZM (Gujarat).

The company has an authorised share capital of ₹7.15 Cr and a paid-up capital of ₹6.86 Cr. It is led by directors including Tejash Maheshchandra Hathi (Managing Director) and Riddhish Natwarlal Tanna.

Its last annual general meeting (AGM) was held on 18 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Harikrupa Logistic Park, Daskroi, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹24.64 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹2.96 Cr (net margin 12%) and EBITDA of ₹4.83 Cr (EBITDA margin 19.6%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 38% over five years.

The company has about 28 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Aptus Pharmaceuticals. As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aptus-pharma.com.

Company Details of Aptus Pharma Limited
CIN U24230GJ2010PLC061957
Registration Number 061957
Incorporation Date 12 August 2010
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Ashutosh Buildcon Opp. Slok 2, Nr. Harikrupa Logistic Park Aslali, Daskroi, Gujarat, India – 382427
  • Industry
    Trading, Wholesale, Other Wholesale
Comprehensive company report
Aptus Pharma Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Aptus Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Aptus Pharma Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

CIN History of Aptus Pharma Limited

Aptus Pharma has one previous CIN (Corporate Identification Number): U24230GJ2010PTC061957. The current CIN is U24230GJ2010PLC061957, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230GJ2010PLC061957Current
U24230GJ2010PTC061957Previous

Associated Brands with Aptus Pharma Limited

Aptus Pharma operates one associated brand: Aptus Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Limited information availableaptuspharma.com

Business Activity of Aptus Pharma Limited

The main business activity of Aptus Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Aptus Pharma Limited

Aptus Pharma Limited currently reports 6 directors and 2 key managerial personnel. 10 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Riddhish Natwarlal TannaDirector17 Jan 20242 Years 8 MonthsCurrent
Jyotiben Hasmukhbhai ChandaranaDirector20 May 20242 Years 4 MonthsCurrent
Chetan Shantilal LalsetaDirector17 Jan 20242 Years 8 MonthsCurrent
Kapilbhai Hasmukhbhai ChandaranaCfo01 Jan 20251 Years 9 MonthsCurrent
Tejash Maheshchandra HathiManaging Director12 Aug 201016 Years 1 MonthsCurrent
Ghanshyam Vinubhai PansuriyaCeo01 Jan 20251 Years 9 MonthsCurrent
Showing 6 of 8 current directors and KMP. View all directors and KMP

Financials of Aptus Pharma Limited FY 2025 filings available

Aptus Pharma Limited reported revenue of ₹24.64 Cr (up 38% YoY) for FY 2025.

Revenue · FY 2025
₹24.64 Cr ▲ 38%
Net profit · FY 2025
₹2.96 Cr margin 12%
EBITDA · FY 2025
₹4.83 Cr margin 19.6%

Compounded Annual Growth Rate (CAGR) of Aptus Pharma Limited

Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 33%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 199%
3 years · compounded
▲ 144%
5 years · compounded
▲ 116%

Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 38% growth in the latest year. EBITDA rose 199% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Aptus Pharma Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹4.83 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹2.96 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Aptus Pharma Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin19.6%••••••••••••••••
Net Profit Margin12%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aptus Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Aptus Pharma Limited

Open charges
₹5 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Others₹5.00 Cr
Latest charge details
DateLenderAmountStatus
27 Feb 2024Others₹5 CrOpen
28 Apr 2023Hdfc Bank Limited₹2 CrSatisfied
15 Jul 2020Others₹5.85 LakhSatisfied
02 Nov 2015Others₹80 LakhSatisfied
30 Aug 2012Central Bank of India₹14 LakhSatisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Aptus Pharma Limited

Employment history and EPFO contributions of people linked to Aptus Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Aptus Pharma Limited

Aptus Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAICA7890D1ZMGujaratActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Aptus Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aptus Pharma Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aptus Pharma Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aptus Pharma Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Aptus Pharma Limited

Activity
18 Jun 2025
Aptus Pharma Limited last Annual general meeting of members was held on 18 Jun 2025 as per latest MCA records.
Activity
31 Mar 2025
Aptus Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
06 Feb 2025
Sejal Harit Palan was appointed as a Director on 06 Feb 2025 & has been associated with this company since 1 year 7 months.
Directors
06 Feb 2025
Vikas Rambhai Jobanputra was appointed as a Director on 06 Feb 2025 & has been associated with this company since 1 year 7 months.
Directors
24 Jan 2025
Ghanshyam Vinubhai Pansuriya was appointed as a Ceo on 24 Jan 2025 & has been associated with this company since 1 year 8 months.
Directors
24 Jan 2025
Kapilbhai Hasmukhbhai Chandarana was appointed as a Cfo on 24 Jan 2025 & has been associated with this company since 1 year 8 months.

Frequently Asked Questions about Aptus Pharma Limited

Aptus Pharma is an active public limited company based in Daskroi, Gujarat, India. The company works in wholesale, within the trading industry. It was incorporated on 12 August 2010 (16+ years old) and is registered under CIN U24230GJ2010PLC061957.

Aptus Pharma reported revenue of ₹24.64 Cr for FY 2025 (up 38% YoY).

Aptus Pharma reported a net profit of ₹2.96 Cr (net margin 12%) and EBITDA of ₹4.83 Cr (EBITDA margin 19.6%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Aptus Pharma is 33% over three years and 38% over five years. In the latest year (FY 2025) revenue rose 38%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Aptus Pharma is 24AAICA7890D1ZM, registered in Gujarat.

The CIN (Corporate Identification Number) of Aptus Pharma is U24230GJ2010PLC061957. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aptus Pharma was incorporated on 12 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Aptus Pharma can be reached through the website aptus-pharma.com. Its registered office is in Daskroi, Gujarat, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available